| 000 | 01064 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517111038.0 | ||
| 264 | 0 | _c20170623 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1365-2559 | ||
| 024 | 7 |
_a10.1111/his.13054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNaidoo, Kalnisha | |
| 245 | 0 | 0 |
_aAn audit of residual cancer burden reproducibility in a UK context. _h[electronic resource] |
| 260 |
_bHistopathology _cJan 2017 |
||
| 300 |
_a217-222 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aChemoradiotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aNeoplasm, Residual _xdiagnosis |
| 650 | 0 | 4 | _aObserver Variation |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aParham, David M | |
| 700 | 1 | _aPinder, Sarah E | |
| 773 | 0 |
_tHistopathology _gvol. 70 _gno. 2 _gp. 217-222 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/his.13054 _zAvailable from publisher's website |
| 999 |
_c26301772 _d26301772 |
||